How to improve outcomes of your viral vectors for gene therapy with high-quality data from biophysical profiling methods
November 4, 2021
Optimizing your vectors for gene therapy is a daunting task. When developing and optimizing AAVs, concerns such as serotype, storage stability, expression method, and genetic fill level must be addressed before a therapeutic vector reaches clinical application. With biophysical characterization tools, it is possible to address these questions and determine the best formulation for your AAV development needs. The proper tool will give you the high-quality data you require, without using lots of precious sample. Watch this video to learn how NanoTemper is addressing the needs of gene therapy researchers.
Overcome bottlenecks in viral vector manufacturing
The success of your gene therapy vectors is dependent on optimal formulation conditions. Finding a buffer t...
Tour Andromeda: how to screen for optimal expression of folded membrane proteins in crude lysate
Poor expression levels, solubilization, and stability — these are the daily challenges that your membrane p...
Sign up to receive the latest NanoTemper news, product updates, event announcements and more